1. Home
  2. RAPT vs EBMT Comparison

RAPT vs EBMT Comparison

Compare RAPT & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • EBMT
  • Stock Information
  • Founded
  • RAPT 2015
  • EBMT 1922
  • Country
  • RAPT United States
  • EBMT United States
  • Employees
  • RAPT N/A
  • EBMT N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • EBMT Major Banks
  • Sector
  • RAPT Health Care
  • EBMT Finance
  • Exchange
  • RAPT Nasdaq
  • EBMT Nasdaq
  • Market Cap
  • RAPT 117.5M
  • EBMT 133.9M
  • IPO Year
  • RAPT 2019
  • EBMT N/A
  • Fundamental
  • Price
  • RAPT $0.75
  • EBMT $17.49
  • Analyst Decision
  • RAPT Hold
  • EBMT
  • Analyst Count
  • RAPT 7
  • EBMT 0
  • Target Price
  • RAPT $5.00
  • EBMT N/A
  • AVG Volume (30 Days)
  • RAPT 829.4K
  • EBMT 48.5K
  • Earning Date
  • RAPT 05-08-2025
  • EBMT 04-29-2025
  • Dividend Yield
  • RAPT N/A
  • EBMT 3.20%
  • EPS Growth
  • RAPT N/A
  • EBMT 26.99
  • EPS
  • RAPT N/A
  • EBMT 1.41
  • Revenue
  • RAPT N/A
  • EBMT $82,271,000.00
  • Revenue This Year
  • RAPT N/A
  • EBMT N/A
  • Revenue Next Year
  • RAPT N/A
  • EBMT $6.33
  • P/E Ratio
  • RAPT N/A
  • EBMT $12.64
  • Revenue Growth
  • RAPT N/A
  • EBMT 0.06
  • 52 Week Low
  • RAPT $0.75
  • EBMT $12.42
  • 52 Week High
  • RAPT $8.58
  • EBMT $18.37
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 33.73
  • EBMT 55.82
  • Support Level
  • RAPT $0.75
  • EBMT $17.09
  • Resistance Level
  • RAPT $0.85
  • EBMT $18.49
  • Average True Range (ATR)
  • RAPT 0.08
  • EBMT 0.37
  • MACD
  • RAPT -0.00
  • EBMT 0.05
  • Stochastic Oscillator
  • RAPT 0.97
  • EBMT 44.44

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About EBMT Eagle Bancorp Montana Inc.

Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.

Share on Social Networks: